Anthony E. Mega

2.8k citations
52 papers · 2.1k · 2 hit papers · h-index 20

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
  • Surgery top 5%
    • Bladder and Urothelial Cancer Treatments

Papers in

    • Renal cell carcinoma treatment 7
    • Prostate Cancer Treatment and Research 7
    • Prostate Cancer Diagnosis and Treatment 5
    • Bladder and Urothelial Cancer Treatments 11

Anthony E. Mega

50 papers receiving 2k citations

Anthony E. Mega's Hit Papers

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial 2021 · 490 citations
4900+3+6Years since publication100200300400500

Peers

Anthony E. Mega
Comparison fields: 5 of 93
  • Oncology 528
  • Surgery 742
  • Pulmonary and Respiratory Medicine 400
  • Endocrine and Autonomic Systems 45
  • Radiology, Nuclear Medicine and Imaging 95
Replace Alexandra Maria Easson with:
Alexandra Maria Easson Canada
Andrea Papadia Italy
Claudio Francesco Feo Italy
Robert Andrew Ord United States
John Carroll Haney United States
Andrew J. Page United States
Marc Ryan Matrana United States
Brian K. Bednarski United States
Daya Nand Sharma India
Hagit Tulchinsky Israel
Anthony E. Mega relative to Alexandra Maria Easson Canada Alexandra Maria Easson's profile →
Citations per field
00.5×2×4×6×7.5×
Alexandra Maria Easson · 1×
Citations per year

Countries citing papers authored by Anthony E. Mega

Since Specialization
Citations

This map shows the geographic impact of Anthony E. Mega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony E. Mega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony E. Mega more than expected).

Fields of papers citing papers by Anthony E. Mega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony E. Mega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony E. Mega. The network helps show where Anthony E. Mega may publish in the future.

Co-authors

The 25 scholars most cited alongside Anthony E. Mega, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anthony E. Mega Line = papers co-authored together Anthony E. Mega links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Hit paper breakdown →
2017512
2
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2021490
3 2019142
4 201979
5 200964
6 202063
7 201558
8 198953
9 200948
10 201340
11 201835
12 199934
13 202233
14 200529
15 201128
16 201527
17 201724
18 199722
19 200122
20 200622

About Anthony E. Mega

Anthony E. Mega is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Hematology, having authored 52 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (11 papers), Renal cell carcinoma treatment (7 papers), Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Innovations in Medical Education (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Patient-Provider Communication in Healthcare (3 papers) and Parvovirus B19 Infection Studies (2 papers). The work is most often cited by research in Oncology (528 citations), Surgery (742 citations), Pulmonary and Respiratory Medicine (400 citations), Endocrine and Autonomic Systems (45 citations) and Radiology, Nuclear Medicine and Imaging (95 citations). Anthony E. Mega has collaborated with scholars based in United States, Kenya and Netherlands. Frequent co-authors include Howard P. Safran, James Gulley, Thomas E. Stinchcombe, Karen L. Kelly, Carolyn D. Britten, Alain Ravaud, Ani Sarkis Balmanoukian, Jeffrey R. Infante, Ding Wang and Michael Schlichting. Their work appears in journals such as American Journal of Hematology, Urologic Oncology Seminars and Original Investigations, The Lancet Oncology, Prostate Cancer and Prostatic Diseases and Journal of Cancer Policy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact